Group 1: Financial Performance and Goals - The company aims to achieve profitability by the second or third quarter of 2025, following a loss in the first quarter [2] - The target for the year is to turn losses into profits through improved operational efficiency and quality [2] Group 2: Order and Revenue Recognition - The typical manufacturing cycle for products ranges from 3 to 9 months, with revenue recognized upon customer acceptance of installation [2] - Domestic orders are confirmed based on the customer's signed acceptance of the installation [2] Group 3: Impact of Tariffs and Supply Chain - The impact of U.S. tariffs on sales is minimal, as exports to the U.S. constitute a small portion of overall revenue [3] - The company has a low dependency on direct imports from the U.S. and has developed self-sufficiency for core components [3] Group 4: International Business Development - In 2024, the company’s export orders exceeded 1 billion RMB for the first time, with significant growth in international markets [3] - The company has established sales service centers in over ten countries to enhance international business [3][4] Group 5: New Products and Business Expansion - The company has expanded its business into new sectors such as peptides, medical beauty, and blood products, achieving notable success [4] - The subsidiary, Chutian Huaton, has diversified its product offerings into emerging fields like wastewater treatment and new energy lithium batteries [4]